Calico Life Sciences | LinkedIn (original) (raw)

Biotechnology Research

South San Francisco, CA 54,190 followers

We're tackling aging, one of life's greatest mysteries

About us

Calico is an Alphabet-founded research and development company whose mission is to harness advanced technologies and model systems to increase our understanding of the biology that controls human aging. We will use that knowledge to devise interventions that enable people to lead longer and healthier lives. Calico’s highly innovative technology labs, its commitment to curiosity-driven discovery science and, with academic and industry partners, its vibrant drug-development pipeline together create an inspiring and exciting place to catalyze and enable medical breakthroughs. Calico is currently seeking exceptional candidates who share our passion for understanding the science of aging and developing therapeutics to address age-related diseases. Explore with us! https://www.calicolabs.com/careers

Industry

Biotechnology Research

Company size

201-500 employees

Headquarters

South San Francisco, CA

Type

Privately Held

Founded

2013

Specialties

biotechnology and scientific research

Locations

Employees at Calico Life Sciences

Updates

We’re exploring the Integrated Stress Response (ISR) because of its possible connection to age-related diseases and its potential as a target for new drug development. Recent research conducted in our labs shows how the ISR impacts cell metabolism and lipid storage, offering new insights into this critical pathway. Our latest findings, published in Nature Communications, represent a step forward in understanding how the ISR affects cellular health and its role in aging. Learn more in this new Calico Story: https://lnkd.in/gZkYHHYs #AgingScience #Aging #PublishedResearch
Explore Life at Calico: Our Regulatory Affairs team bridges science and governance to help Calico introduce new medical treatment options that may help alleviate age-related diseases and fulfill high unmet medical needs. Learn more about Anna Rodriguez, Director of Regulatory Affairs, and other members of the Calico team here: https://lnkd.in/gdFFYBHb
Just published in Nature Portfolio: A recent seven-year study in collaboration with The Jackson Laboratory sheds new light on the relationship between genetics, diet, health, and longevity. Our teams collected biological data throughout the lifespans of nearly 1,000 genetically diverse mice to better understand the physiological impacts of caloric restriction and intermittent fasting. One of the highlights of the paper was how much genetics played a role in determining lifespan — far more than diet. Scientists also found that caloric restriction provided lifespan benefits for mice regardless of whether they started with high or low body weight. Actually, the mice that maintained more weight and higher body fat on the tested diets had longer lifespans. These findings challenge the prevailing belief that metabolic benefits are the primary drivers of lifespan extension through dietary interventions. This research underscores the importance of integrating genetic and phenotypic data into studies of dietary interventions, potentially paving the way for more effective strategies to promote healthy aging. Learn more in this feature article from Nature: https://lnkd.in/getUJkgE #AgingScience #Longevity
Eating less can lead to a longer life: massive study in mice shows why nature.com
“The whole idea that aging is just something that happens and there’s nothing you can do about it, just went out the window…. And so it changed everything actually.” Cynthia Kenyon, PhD, Calico’s Vice President of Aging Research, recently spoke at The Atlantic Festival 2024 about her decades of contributions to the field of aging research– beginning with her pioneering discovery that has since become one of the defining studies in the field– and how scientific breakthroughs might one day lead to interventions that enable people to live longer and healthier lives. Watch the full discussion here: https://lnkd.in/erFMHjmA
At Calico, we combine the best parts of a traditional biotech company and academic institution, without the constraints of either. Our scientists ask tough questions about aging and age-related diseases, with the freedom and support to answer them, and then pursue their science in support of potentially advancing it to the clinic. Learn more about how Calico’s unique approach and culture enable Manoj and his colleagues to advance impactful research and devise potential interventions that may one day extend longevity and healthspan: https://lnkd.in/gdFFYBHb #ExploreWithUs #ScienceCareers
It's #PostdocAppreciationWeek, and we're proud to highlight the impactful work of some of our postdoctoral fellows who help drive scientific discovery at Calico. Thula Yoganathan is a postdoc whose research aims to understand how heart failure develops as we age, particularly heart failure with preserved ejection fraction—a condition where the heart struggles to relax and fill with blood, even though it pumps effectively. Through her work at Calico, Thula is developing new preclinical models and imaging methods to study heart failure, helping to bridge the gap between preclinical research and clinical practice. 🔊Listen to Thula as she shares how her work is contributing to potential breakthroughs in heart disease treatment. Postdocs are integral to our mission of understanding aging and age-related diseases. Our postdoc program is one way we support early career scientists as they explore new frontiers in research.#ScienceofAging #HeartHealth #PostdocResearch #ScienceCareers
It's #PostdocAppreciationWeek, and we’re celebrating the impactful contributions of our postdoctoral fellows who help advance the science of aging here at Calico. Sammy Villa is a postdoc in cell biology researching how cells manage protein levels to discover the strategies they use to stay healthy and function properly. Through his work, Sammy finds proteins and pathways involved in protein degradation and explores how and when these pathways control the removal of natural substrates. 🔊Listen to Sammy describe how he identifies the key strategies cells use to regulate their protein levels and maintain their health. Our postdocs are integral to our efforts in understanding aging and age-related diseases. We’re proud to support early career scientists like Sammy through our postdoc program.#ScienceofAging #CellBiology #PostdocResearch #ScienceCareers
Congratulations to Cynthia Kenyon, Calico’s Vice President of Aging Research, for being awarded the Lord Cohen Medal, a prestigious honor recognizing leaders in the field of aging. Awarded by the British Society for Research on Aging (BSRA), the Medal has only been awarded 16 times in the past 40 years, and is given to recipients who’ve made outstanding contributions to aging research. As part of this recognition, Cynthia delivered the prize lecture at the BSRA Annual Scientific Meeting on September 5 at University of Birmingham. Titled “Genes and processes that control the rate of aging,” Cynthia's talk discussed her pioneering studies with C. elegans showing that the rate of aging is not immutable, as previously thought, but instead is plastic and under active genetic control by specific genes and hormones. Congratulations, Cynthia, on this well-deserved honor!
Aging is complex and at Calico we are trying to disentangle the symptoms and drivers of the aging process. Harnessing advanced technologies and model systems, we are generating insights that are helping us answer key questions about aging. The more we understand the biology that controls aging, the better equipped we are to pursue new interventions that may hold potential for increasing healthspan.#ScienceofAging #AgingResearch
Earlier this month, Calico officially welcomed Michael Lenardo, M.D., as our new Chief Scientific Officer. In his first days on-site at Calico, Dr. Lenardo spent time touring our labs, meeting the team and settling into his new role. Dr. Lenardo is an exceptional physician-scientist and medical researcher with a remarkable 40-year career marked by leadership, innovation, and collaboration. He joins Calico from the National Institutes of Health, where he served as Co-Director of the National Institute of Allergy and Infectious Diseases (NIAID) Clinical Genomics Program. Welcome to Calico, Dr. Lenardo. We’re excited to have you on the team!

Join now to see what you are missing

Join now

Calico Life Sciences | LinkedIn (original) (raw)

Biotechnology Research

South San Francisco, CA 54,190 followers

We're tackling aging, one of life's greatest mysteries

About us

Locations

Employees at Calico Life Sciences

Updates

Join now to see what you are missing

Similar pages

Browse jobs

Funding